Loading...
Loading...
Among the 7 tracked institutional investors we monitor, FATE (FATE THERAPEUTICS INC) is held with a combined value of $28.46M across 25,338,752 shares. The largest holder is BlackRock, Inc. with a position worth $12.08M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$28.46M
Total Shares Held
25,338,752
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $12.08M | 0.00% | -1.1% |
| 2 | VANGUARD GROUP INC | $8.82M | 0.00% | New |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $3.57M | 0.01% | +26.0% |
| 4 | STATE STREET CORP | $2.72M | 0.00% | -0.1% |
| 5 | CITADEL ADVISORS LLC | $1.16M | 0.00% | +24.0% |
| 6 | FMR LLC | $57.11K | 0.00% | +273.1% |
| 7 | Point72 Asset Management, L.P. | $51.74K | 0.00% | -97.2% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of FATE with a position worth $12.08M, representing 0.00% of their portfolio. In total, 7 institutional investors hold FATE with a combined value of $28.46M.
In the most recent quarter, 1 fund opened a new position in FATE. Additionally, 3 increased their holdings and 3 reduced their positions.
Institutional investors hold $28.46M worth of FATE stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $12.08M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For FATE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their FATE positions.